Μολνουπιραβίρη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Μολνουπιραβίρη" in Greek language version.

refsWebsite

Global rank Greek rank

8nih.gov

4^th place

4doi.org

2^nd place

3^rd place

1kathimerini.gr

2,366^th place

7^th place

1web.archive.org

1^st place

1go.com

48^th place

159^th place

1euronews.com

612^th place

170^th place

1science.org

1,160^th place

6,797^th place

1arstechnica.com

388^th place

918^th place

1patents.google.com

1,182^nd place

4,608^th place

arstechnica.com

«Meet molnupiravir, Merck's Thor-inspired pill that hammers COVID». Ars Technica. Οκτωβρίου 2021. Ανακτήθηκε στις 2 Οκτωβρίου 2021.

doi.org

dx.doi.org

«Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine 11 (515): eaax5866. October 2019. doi:10.1126/scitranslmed.aax5866. PMID 31645453.
«Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research 218: 16–28. April 2020. doi:10.1016/j.trsl.2019.12.002. PMID 31945316.
«Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2». Antimicrobial Agents and Chemotherapy 65 (5). March 2021. doi:10.1128/AAC.02428-20. PMID 33649113.
«The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva». Journal of Pharmaceutical and Biomedical Analysis 206: 114356. September 2021. doi:10.1016/j.jpba.2021.114356. PMID 34509661.

euronews.com

gr.euronews.com

«Η Βρετανία ενέκρινε το αντιικό χάπι της Merck για τη θεραπεία του κορονοϊού». euronews. 4 Νοεμβρίου 2021. Ανακτήθηκε στις 5 Νοεμβρίου 2021.

go.com

abcnews.go.com

«Daily pill to treat COVID could be just months away». ABC News. 29 Σεπτεμβρίου 2021. Αρχειοθετήθηκε από το πρωτότυπο στις 29 Σεπτεμβρίου 2021. Ανακτήθηκε στις 29 Σεπτεμβρίου 2021.

kathimerini.gr

«Pfizer εναντίον Merck: Όσα γνωρίζουμε για τα δύο χάπια κατά της Covid-19». Η ΚΑΘΗΜΕΡΙΝΗ. 5 Νοεμβρίου 2021. Ανακτήθηκε στις 5 Νοεμβρίου 2021.

nih.gov

pubmedcentral.nih.gov

«Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine 11 (515): eaax5866. October 2019. doi:10.1126/scitranslmed.aax5866. PMID 31645453.
«Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research 218: 16–28. April 2020. doi:10.1016/j.trsl.2019.12.002. PMID 31945316.
«Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2». Antimicrobial Agents and Chemotherapy 65 (5). March 2021. doi:10.1128/AAC.02428-20. PMID 33649113.
«The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva». Journal of Pharmaceutical and Biomedical Analysis 206: 114356. September 2021. doi:10.1016/j.jpba.2021.114356. PMID 34509661.

ncbi.nlm.nih.gov

«Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine 11 (515): eaax5866. October 2019. doi:10.1126/scitranslmed.aax5866. PMID 31645453.
«Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research 218: 16–28. April 2020. doi:10.1016/j.trsl.2019.12.002. PMID 31945316.
«Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2». Antimicrobial Agents and Chemotherapy 65 (5). March 2021. doi:10.1128/AAC.02428-20. PMID 33649113.
«The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva». Journal of Pharmaceutical and Biomedical Analysis 206: 114356. September 2021. doi:10.1016/j.jpba.2021.114356. PMID 34509661.

patents.google.com

US application 20200276219, Painter, George R.; Bluemling, Gregory R. & Natchus, Michael G. et al., "N4-hydroxycytidine and derivatives and anti-viral uses related thereto", published 2020-09-03, assigned to Emory University

science.org

Lowe, Derek (13 October 2021). Molnupiravir Mutations. https://www.science.org/content/blog-post/molnupiravir-mutations. Ανακτήθηκε στις 13 October 2021.

web.archive.org

«Daily pill to treat COVID could be just months away». ABC News. 29 Σεπτεμβρίου 2021. Αρχειοθετήθηκε από το πρωτότυπο στις 29 Σεπτεμβρίου 2021. Ανακτήθηκε στις 29 Σεπτεμβρίου 2021.